Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab

Japanese Journal of Ophthalmology

Volumn 56, Issue 2, 2012, Pages 159-164

  Yunoki, Tatsuya ^a   Miyakoshi, Akio ^a   Nakamura, Tomoko ^a   Fujita, Kazuya ^a   Fuchizawa, Chiharu ^a   Hayashi, Atsushi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Bevacizumab; Branch retinal vein occlusion; Intravitreal injection; IS OS line; Macular edema

Indexed keywords

BEVACIZUMAB;

AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MEAN RETINAL THICKNESS; MORPHOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA FOVEA; RETINA MACULA EDEMA; RETROSPECTIVE STUDY; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; PROGNOSIS; RETINA; RETINAL VEIN OCCLUSION; RETREATMENT; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84862810281     PISSN: 00215155     EISSN: 16132246     Source Type: Journal    
DOI: 10.1007/s10384-011-0114-3     Document Type: Article

References (15)

1. Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E. Longterm outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina. 2007;27: 49-54. (Pubitemid 46095830)
2. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271-82.
3. Parodi M, DI Stefano G,Ravalico G. Grid laser treatment for exudative retinal detachment secondary to ischemic branch retinal vein occlusion. Retina. 2008;28:97-102.
4. Jaissle G, Leitritz M, Gelisken F, Ziemssen F, Bartz-Schmidt KU, Szurman P. One-year results after intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2009;247:27-33.
5. Kondo M, Kondo N, Ito Y, Kachi S, Kikuchi M, Yasuma TR, et al. Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion. Retina. 2009;29: 1242-8.
6. Kreutzer TC, Alge CS, Wolf AH, Kook D, Burger J, Strauss R, et al. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol. 2008;92:351-5. (Pubitemid 351363529)
7. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina. 2007; 27:419-25. (Pubitemid 46624280)
8. Hoeh AE, Ach T, Schaal KB, Scheuerle AF, Dithmar S. Longterm follow-up of OCT-guided bevacizumab treatment of macular edema due to retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2009;247:1635-41.
9. Ach T, Hoeh AE, Schaal KB, Scheuerle AF, Dithmar S. Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2010;248:155-9.
10. Hoeh AE, Ruppenstein M, Ach T, Dithmar S. OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2010;248: 1567-72.
11. Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ. Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. 2008;246:1241-8.
12. Mitamura Y, Hirano K, Baba T, Yamamoto S. Correlation of visual recovery with presence of photoreceptor inner/outer segment junction in optical coherence images after epiretinal membrane surgery. Br J Ophthalmol. 2008;93:171-5.
13. Noma H, Funatsu H, Yamasaki M, Tsukamoto H, Mimura T, Sone T, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol. 2005;140: 256-61.
14. Sakamoto A, Tsujikawa A, Ota M, Yamaike N, Kotera Y, Miyamoto K, et al. Evaluation of potential visual acuity in eyes with macular oedema secondary to retinal vein occlusion. Clin Exp Ophthalmol. 2009;37:208-16.
15. Kriechbaum K, Prager F, Geitzenauer W, Benesch T, Schütze C, Simader C, et al. Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year. Ophthalmology. 2009;116:2415-21.